Cancer Cachexia Clinical Trial
Official title:
A 12-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Phase II Study Comparing the Safety, Tolerability and Beneficial Effects of Daily Doses of RC-1291 and Placebo in Patients With Cancer Anorexia/Cachexia
Activation of Ghrelin receptors have been demonstrated to stimulate appetite. RC-1291 HCl, by virtue of its ghrelin like activity and Growth Hormone releasing effects may have a dual role in the reversal of cancer induced anorexia and cachexia. This placebo controlled study will evaluate the safety and efficacy of RC-1291 HCl in cancer patients with cachexia.
Anorexia and cachexia are devastating complications in late-stage cancer patients and is strongly associated with mortality in these patients. Activation of Ghrelin receptors have been demonstrated to stimulate appetite. RC-1291 HCl, by virtue of its ghrelin like activity and Growth Hormone releasing effects may have a dual role in the reversal of cancer induced anorexia and cachexia. This placebo controlled study will evaluate the safety and efficacy of RC-1291 HCl in cancer patients with anorexia and cachexia. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02553187 -
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
|
Phase 4 | |
Recruiting |
NCT02848807 -
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life
|
N/A | |
Active, not recruiting |
NCT01206335 -
Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia
|
Phase 2 | |
Completed |
NCT02359123 -
Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients
|
N/A | |
Completed |
NCT00267358 -
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
|
Phase 2 | |
Completed |
NCT03144128 -
Vitamin D for Muscle Metabolic Function in Cancer Cachexia
|
N/A | |
Completed |
NCT01614990 -
Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia
|
Phase 2 | |
Recruiting |
NCT04067167 -
Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases
|
N/A | |
Recruiting |
NCT04065815 -
Protein-rich Nutritional Therapy Combined With Time-efficient Exercise in Cancer Therapy
|
N/A | |
Active, not recruiting |
NCT03851133 -
Florida Pancreas Collaborative Next Generation Biobank
|
||
Completed |
NCT05264038 -
A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514
|
Phase 1 | |
Recruiting |
NCT04127981 -
Medical Imaging of Cachexia
|
N/A | |
Not yet recruiting |
NCT05262192 -
Nutrition Education and Quality of Life in Cancer Cachexia
|
N/A | |
Completed |
NCT04153019 -
PSYCHO-EDUCATIONAL AND REHABILITATIVE INTERVENTION FOR CANCER CACHEXIA (PRICC)
|
N/A | |
Terminated |
NCT02066363 -
Study of Parenteral Nutrition to Patients With Gastrointestinal Cancer
|
N/A | |
Terminated |
NCT01505764 -
The Role of Ghrelin in Cancer Cachexia
|
Phase 2 | |
Completed |
NCT00219817 -
Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss
|
Phase 2 | |
Completed |
NCT00094562 -
A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss
|
Phase 2 | |
Recruiting |
NCT04131478 -
Effect of Gene Polymorphisms on the Pathogenesis of Cancer Cachexia
|
||
Recruiting |
NCT05915325 -
Physical Training for Elderly Cancer Patients With Cachexia
|
N/A |